Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 107

    1.

    Expanding the armamentarium for the spondyloarthropathies.

    Peloso PM, Braun J.

    Arthritis Res Ther. 2004;6 Suppl 2:S36-43. Epub 2004 Jun 21. Review.

    PMID:
    15228620
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

    Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

    Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

    PMID:
    17049139
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.

    McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, Hill RA, Jones A, Mujica Mota R, Walley T.

    Health Technol Assess. 2007 Aug;11(28):1-158, iii-iv. Review.

    PMID:
    17651658
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    Disease-modifying antirheumatic drug therapy for spondyloarthropathies: advances in treatment.

    Mease PJ.

    Curr Opin Rheumatol. 2003 May;15(3):205-12. Review.

    PMID:
    12707572
    [PubMed - indexed for MEDLINE]
    5.

    New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy.

    Braun J, de Keyser F, Brandt J, Mielants H, Sieper J, Veys E.

    Curr Opin Rheumatol. 2001 Jul;13(4):245-9. Review.

    PMID:
    11555723
    [PubMed - indexed for MEDLINE]
    6.

    Current use of biologicals for the treatment of spondyloarthropathies.

    Keyser FD, Mielants H, Veys EM.

    Expert Opin Pharmacother. 2001 Jan;2(1):85-93. Review.

    PMID:
    11336571
    [PubMed - indexed for MEDLINE]
    7.

    Biological therapies in the spondyloarthritides--the current state.

    Braun J, Sieper J.

    Rheumatology (Oxford). 2004 Sep;43(9):1072-84. Epub 2004 Jun 8. Review.

    PMID:
    15187239
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritis.

    Kavanaugh A, Tutuncu Z, Catalan-Sanchez T.

    Curr Opin Rheumatol. 2006 Jul;18(4):347-53. Review.

    PMID:
    16763453
    [PubMed - indexed for MEDLINE]
    9.

    Novel approaches in the treatment of ankylosing spondylitis and other spondyloarthritides.

    Braun J, van der Heijde D.

    Expert Opin Investig Drugs. 2003 Jul;12(7):1097-109. Review.

    PMID:
    12831346
    [PubMed - indexed for MEDLINE]
    10.

    Biologic therapies in the spondyloarthritis: new opportunities, new challenges.

    Braun J, Brandt J, Listing J, Rudwaleit M, Sieper J.

    Curr Opin Rheumatol. 2003 Jul;15(4):394-407. Review.

    PMID:
    12819466
    [PubMed - indexed for MEDLINE]
    11.

    TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.

    Tobin AM, Kirby B.

    BioDrugs. 2005;19(1):47-57. Review.

    PMID:
    15691217
    [PubMed - indexed for MEDLINE]
    12.

    Drugs that block tumour necrosis factor: experience in patients with rheumatoid arthritis.

    Moreland LW.

    Pharmacoeconomics. 2004;22(2 Suppl 1):39-53. Review. Erratum in: Pharmacoeconomics. 2004;22(8):547.

    PMID:
    15157003
    [PubMed - indexed for MEDLINE]
    13.

    [Therapeutic use of anti-TNF-alpha agents in spondyloarthropathies].

    Wendling D, Claudepierre P, Lohse A, Toussirot E, Breban M.

    Presse Med. 2003 Oct 4;32(32):1517-24. Review. French.

    PMID:
    14534471
    [PubMed - indexed for MEDLINE]
    14.

    [Spondylarthropathies and anti-TNFalpha drugs].

    Pavy S, Allanore Y, Kahan A.

    Rev Med Interne. 2005 Sep;26(9):717-24. Epub 2005 Mar 17. Review. French.

    PMID:
    16154026
    [PubMed - indexed for MEDLINE]
    16.

    [Treatment outcome of spondyloarthropathy with infliximab].

    Głowska A, Wiland P, Szechiński J.

    Pol Arch Med Wewn. 2005 Jan;113(1):42-7. Polish.

    PMID:
    16130600
    [PubMed - indexed for MEDLINE]
    17.

    Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab.

    Brandt J, Haibel H, Reddig J, Sieper J, Braun J.

    J Rheumatol. 2002 Jan;29(1):118-22.

    PMID:
    11824947
    [PubMed - indexed for MEDLINE]
    18.

    Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides.

    Braun J, Baraliakos X, Brandt J, Sieper J.

    Scand J Rheumatol. 2005 May-Jun;34(3):178-90. Review.

    PMID:
    16134723
    [PubMed - indexed for MEDLINE]
    19.

    Treatment update on spondyloarthropathy.

    Anandarajah A, Ritchlin CT.

    Curr Opin Rheumatol. 2005 May;17(3):247-56. Review.

    PMID:
    15838232
    [PubMed - indexed for MEDLINE]
    20.

    Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

    Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

    Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

    PMID:
    16948890
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk